81 -6 (80) 2025 - Sh.A. Mustafayeva - FUNCTIONAL AND MORPHOLOGICAL STATE OF KIDNEY CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS

FUNCTIONAL AND MORPHOLOGICAL STATE OF KIDNEY CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS

Sh.A. Mustafayeva - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

This review is dedicated to characterizing the risk of kidney damage in patients with rheumatoid arthritis. One of the pressing problems in modern medicine is kidney damage in rheumatoid arthritis. Issues of the prevalence and risk factors for chronic kidney disease are considered. The kidneys are affected more often in rheumatoid arthritis than they are diagnosed. Consequently, early diagnosis of kidney damage in patients with rheumatoid arthritis has important clinical and prognostic significance. Possible morphological variants and mechanisms of kidney damage are also considered. In rheumatoid arthritis, the occurrence of chronic kidney disease depends primarily on the duration of the disease and its nature.

Keywords: rheumatoid arthritis, amyloidosis, chronic kidney disease, glomerulonephritis

First page

392

Last page

396

For citation:Sh.A. Mustafayeva - FUNCTIONAL AND MORPHOLOGICAL STATE OF KIDNEY CELLS IN PATIENTS WITH RHEUMATOID ARTHRITIS//New Day in Medicine 6(80)2025 392-396 https://newdayworldmedicine.com/en/new_day_medicine/6-80-2025

List of References

1. Bacon P.A., Moots R.J. Extra-articular rheumatoid arthritis // In Koopman W.J. Arthritis and allied conditions. 13-th. Ed. -1997. P.1071-1089.
2. Crowson C.S., Matteson E.L., Myasoedova E, et al. The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic dis-eases // Arthritis Rheum. 2011 Mar;63(3):633-9.doi:10.1002/art.30155
3. England BRM, Mikuls TR. Epidemiology of, risk factors for, and possible causes of rheumatoid ar-thritis.2020.
4. Fernández-Nebro A, Tomero E, Ortiz-Santamaría V, et al. Treatment of rheumatic inflamma-tory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists // Am J Med. 2005;118(5):52-556.doi:10.1016/j.am-jmed.2005.01.028
5. Gois M, Carvalho F, Sousa H, et al. Renal involvement in rheumatoid arthritis: analysis of 53 renal biopsies. Port J Nephrol Hypert. 2017;31(1):25-30.
6. Galarraga B, Khan F, Kumar P, et al. C-reactive protein: the underlying cause of icrovascular dysfunction in rheumatoid arthritis. Rheumatology (Oxford). 2008;47(12):1780-4. doi: 0.1093/rheumatology/ken386
7. Gottenberg JE, Merle-Vincent F, Bentaberry F, et al. Anti-tumor necrosis factor alpha therapy in fif-teen patients with AA amyloidosis secondary to inflam-matory arthritides: a followup report of tolerability and efficacy // Arthritis Rheum. 2003;48(7):2019-2024. doi:10.1002/art.11163
8. Hickson LJ, Crowson CS, Gabriel SE, et al. Development of reduced kidney function in rheumatoid arthritis. Am J Kidney Dis. 2014;63:206-13. doi: 0.1053/j.ajkd.2013.08.010
9. Helin HJ, Korpela MM, Mustonen JT, Pasternack AI. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arth Rheum. 1995;38(2):242-7. doi: 10.1002/art.1780380213
10. Helin H.J., Korpela M.M., Mustonen J.T., Pasternack A.I. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis // Arthritis Rheum. 1995. V. 38 (2). P. 242—247.

    file

    download